LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
23,821,204
Share change
-407,479
Total reported value
$828,494,536
Put/Call ratio
847%
Price per share
$34.78
Number of holders
95
Value change
-$6,498,436
Number of buys
49
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q3 2017

As of 30 Sep 2017, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,821,204 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, FMR LLC, PERCEPTIVE ADVISORS LLC, JENNISON ASSOCIATES LLC, Consonance Capital Management LP, BlackRock Inc., Broadfin Capital, LLC, RTW INVESTMENTS, LP, VANGUARD GROUP INC, and STATE STREET CORP. This page lists 95 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.